Medisafe AI Healthcare Assistant Platform Involves Controversy Over 'Gunshot' Accusations | Production Company Issues Statement, Alleging Involved Party Attempted to Pay for Public Opinion Control
06:49
Developed by a Hong Kong secondary school student, the AI healthcare assistant platform 'Medisafe' has recently sparked a 'gunshot' controversy. A foreign website, 'AI Health Studio', claimed that it assisted in creating the Medisafe platform in eight weeks, later changing its statement to say it helped with the software's 'commercialization'. After nearly two months of the incident, the founder of the website, Ahmed Jemaa, issued a statement on Monday (4th), stating that he was entrusted by 'Dr. Roberta Pang', the mother of the involved secondary school student, to handle the project, but was never informed that it would be used for competition. Afterwards, the other party indicated that they wanted to pay to control public opinion, requesting the company to define 'Medisafe' as 'commercial promotion' rather than 'from-scratch build'.
The founder of the foreign website, Ahmed Jemaa, posted a four-page statement on LinkedIn yesterday. Website founder: The company received payment for developing Medisafe.
The AI healthcare assistant online platform 'Medisafe', developed by a secondary school student, claims that it can help doctors prescribe drugs by comparing drug databases through artificial intelligence. However, the project previously sparked controversy over non-originality, as a foreign website claimed that it assisted in developing the Medisafe platform in eight weeks, later changing its statement to say it helped with the software's 'commercialization'. The Geneva Award jury previously stated that they had carefully reviewed the case and believed that the contestant's submitted information was valid and met the competition standards, so the silver award will remain.